Literature DB >> 6327071

A novel alteration in the structure of an activated c-myc gene in a variant t(2;8) Burkitt lymphoma.

R Taub, K Kelly, J Battey, S Latt, G M Lenoir, U Tantravahi, Z Tu, P Leder.   

Abstract

We have characterized a variant Burkitt lymphoma in which translocation joins the immunoglobulin kappa locus on chromosome 2 to the c-myc gene on chromosome 8. This Burkitt lymphoma is especially interesting because, in contrast to the more common lymphomas that carry 8;14 translocations, it carries a translocation that involves a light chain locus and occurs 3' to and at least 20 kb downstream of the c-myc gene. Furthermore, the c-myc gene from the translocated chromosome is abnormally expressed in that there is a characteristic shift in c-myc promoter utilization and an increase in c-myc transcript. These disturbances could be explained by novel structural alterations that occur in the c-myc gene and include a duplication of a 2.5 kb segment of DNA containing the two c-myc promoters and their untranslated leader exons. Interestingly, these alterations arise at a considerable distance from the translocation breakpoint.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6327071     DOI: 10.1016/0092-8674(84)90381-7

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  34 in total

1.  Molecular hybridization studies with scrapie brain nucleic acids. II. Differential expression in scrapie hamster brain.

Authors:  T Borrás; J J Merendino; C J Gibbs
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

Review 2.  Biology and treatment of adult acute lymphoblastic leukemia.

Authors:  L Levitt; R Lin
Journal:  West J Med       Date:  1996-02

3.  Generation of a variant t(2;8) translocation of Burkitt's lymphoma by site-specific recombination via the kappa light-chain joining signals.

Authors:  P Hartl; M Lipp
Journal:  Mol Cell Biol       Date:  1987-06       Impact factor: 4.272

4.  Genetic characterization of human c-rel sequences.

Authors:  E Brownell; S J O'Brien; W G Nash; N Rice
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

5.  Describing sequencing results of structural chromosome rearrangements with a suggested next-generation cytogenetic nomenclature.

Authors:  Zehra Ordulu; Kristen E Wong; Benjamin B Currall; Andrew R Ivanov; Shahrin Pereira; Sara Althari; James F Gusella; Michael E Talkowski; Cynthia C Morton
Journal:  Am J Hum Genet       Date:  2014-04-17       Impact factor: 11.025

6.  Three breakpoints of variant t(2;8) translocations in Burkitt's lymphoma cells fall within a region 140 kilobases distal from c-myc.

Authors:  B Henglein; H Synovzik; P Groitl; G W Bornkamm; P Hartl; M Lipp
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

7.  Somatic mutation and transcriptional deregulation of myc in endemic Burkitt's lymphoma disease: heptamer-nonamer recognition mistakes?

Authors:  B Morse; V J South; P G Rothberg; S M Astrin
Journal:  Mol Cell Biol       Date:  1989-01       Impact factor: 4.272

Review 8.  Human cancer and cellular oncogenes.

Authors:  S Nishimura; T Sekiya
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

9.  Transcriptional arrest within the first exon is a fast control mechanism in c-myc gene expression.

Authors:  D Eick; G W Bornkamm
Journal:  Nucleic Acids Res       Date:  1986-11-11       Impact factor: 16.971

10.  Premature termination of transcription from the P1 promoter of the mouse c-myc gene.

Authors:  S Wright; L F Mirels; M C Calayag; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.